Charleston, S.C., (September 22, 2005) - QualiLife Pharmaceuticals, Inc., the makers of Zestra™ Feminine Arousal Fluid, has announced the hiring of Alan W. Fink to the post of president reporting directly to the Board of Directors. The company has also announced the change of its company name to Zestra Laboratories, Inc., which will readily identify it in the market and enable rapid branding of the "Zestra" name as the "gold standard" solution in women's sexual health.

Zestra Laboratories has increased its points of distribution to approximately 15,000 retail stores in the past six months both domestically and internationally. Fink's appointment is consistent with the company's continuing growth plans. As a senior marketing executive, Fink has thirty years of experience successfully launching women's health and beauty products for Clairol, Chesebrough Ponds and Schick into the channels of distribution inherently natural to the Zestra launch.

"After an exhaustive executive search, Mr. Fink's proven expertise serves to ensure the Company will maximize the immense commercial opportunity for Zestra," said pharmacist Martin Crosby, founder and chairman of Zestra. "He is charged with building the Sales and Marketing team, including external sales reps and the support team to reach its goal of 40,000 retail outlets by the end of the first quarter of 2006.

"Alan's experience in supporting retail chains with in-store programs has already demonstrated strong sales results in just the past few weeks. He has launched consumer products with annual sales of several hundred million dollars and has intimate knowledge of the broad channels of distribution available for Zestra. Appointing Mr. Fink as President was vital for quickly establishing Zestra as a household brand name and a highly profitable company."

"In my numerous new product launch successes - the timing to launch a unique product was most important. The time for launching Zestra today is perfect," Fink commented. "It has a long lead-time over any other product. There are no FDA-approved prescription drugs to treat female sexual problems. There is no competitive consumer product in the women's market that is proven to work as well or as quickly. This is an irresistible opportunity for all of us at Zestra Laboratories to make a real difference in women's lives."

Widely embraced by knowledgeable healthcare professionals and consumers, Zestra is the only non-prescription product that is clinically proven and published in respected medical journals.

Zestra Laboratories recently announced the acceptance of its expanded 2005 clinical trial of Zestra by the National Institutes of Health (NIH). This Phase 3 type study will evaluate the efficacy and safety of Zestra compared to placebo oil in 200 women diagnosed with acquired mixed interest/desire/arousal/orgasm disorders in conditions of home use in conjunction with sexual activities. The Zestra study is the only registered study to directly address women's sexual problems. The study is a randomized, placebo-controlled, double-blind, parallel design trial and a description can be viewed at www.ClinicalTrials.gov.

Zestra's efficacy was originally validated in a randomized, placebo-controlled, double-blind, crossover design clinical trial and published in a peer-reviewed medical journal in 2003. Study results showed that 85% of women using Zestra experienced increased sexual pleasure, compared to only 10% who used the placebo oil. Zestra is the only topical product that has a well-designed crossover clinical study to back its claims, with robust results.

Results of the study are published in respected medical journals including: The Journal of Sex & Marital Therapy; Women's Health Care: A Practical Journal for Nurse Practitioners; Obstetrical and Gynecological Survey; Clinical Proceedings - Association of Reproductive Health Professionals; WebMD; National Women's Health Resource Center - Health & Sexuality and others.

About Zestra™ Feminine Arousal Fluid (U.S. Patent 6,737,084
Zestra is designed to increase female sexual sensation, arousal and pleasure when topically applied. The ingredients in Zestra are not found in any other women's sexual product. No other product is proven to be more effective for increasing female sexual pleasure, satisfaction or libido. Ingredients: PA-Free Borage Seed Oil, Evening Primrose Oil, Angelica Extract, Coleus Extract, Vitamin C, Vitamin E and natural fragrances. More information is available at www.zestraforwomen.com.

In the United States, Zestra is available nationwide in Walgreen's, CVS, Rite Aid pharmacies and Duane Reade drugstores in NYC.

Zestra is also available in Asia/Pacific Rim, United Kingdom, Ireland and South Africa. To learn more visit www.zestra-asia.com, www.zestraforwomen.co.uk and www.zestra.co.za.

About Zestra Laboratories, Inc.
Formerly QualiLife Pharmaceuticals, Zestra Laboratories, Inc. is a science-driven company focused on developing clinically proven consumer products for Women's Health. Since 1996, the Company has leveraged its expertise in pharmacology; pharmaceutical technologies and women's sexual health to "design and develop" patented consumer products for large unsatisfied markets.

CORPORATE CONTACT:
Martin G. Crosby
Chairman & Chief Science Officer
Zestra Laboratories, Inc.
4055 Faber Place Drive, Suite 300
Charleston, SC 29405
843.402.0901 (phone)
843.402.0919 (fax)
www.zestraforwomen.com

Source: Zestra Laboratories, Inc.

Download the PDF version.